Reyes, Dolores D.
HRN: 17-19-76 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/10/2022
08/17/2022
IVT
600mg
Q8hrs
Soft Tissue Mass
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueEye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes